Citation: yun-dan d., et al.Comparison of outcomes following mitral valve repair versus replacement for chronic ischemic mitral regurgitation: a meta-analysis.Thorac cardiovasc surg.2017 sep;65(6):432-441.Doi: 10.1055/s-0036-1580603.Pmid: 27056301.Epub 2016 apr 7 earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information via literature regarding the safety and effectiveness of mitral valve repair versus replacement for ischemic mitral regurgitation.All data were collected from a meta-analysis review of 10 retrospective studies published between 1986 and 2011.The study population included 2,324 patients (predominantly male, mean age 67 years), 98 of whom were implanted with medtronic duran ancore annuloplasty rings and 98 of whom were implanted with medtronic cg future band annuloplasty bands (no serial numbers provided).Among all patients, 30-day and 5-year post-operative mortality were noted, but numbers of deaths were not given and no further information was provided.Based on the available information medtronic product was not directly associated with the deaths.Among all patients, adverse events included: need for re-operation, recurrence of moderate-severe mitral regurgitation and acute respiratory failure.Based on the available information medtronic product may have been associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
|